For more than 40 years, RTOG studies have defined new standards of care for cancer patients. An international multi-institutional clinical cooperative group funded primarily by the National Cancer Institute (NCI), RTOG investigates new radiation therapy treatment strategies alone or in conjunction with surgery or chemotherapeutic drugs. RTOG also conducts robust translational research and vigorously investigates patient quality-of-life issues. Walter J. Curran, Jr., MD is the RTOG Group Chair and Executive Director of the Winship Cancer Institute at Emory University.
As part of the NCI's restructuring of its clinical trials cooperative group program, RTOG will be conducting clinical research with the National Surgical Adjuvant Breast and Bowel Project and the Gynecologic Oncology Group under NRG Oncology.
Since its inception in 1999, ACRIN has conducted over 40 clinical trials including landmark breast and lung screening trials. As a multi-institutional clinical cooperative group, ACRIN conducts medical imaging research encompassing a wide range of imaging modalities. Funded primarily by the NCI, ACRIN investigates scientific questions about cancer detection, staging, and treatment monitoring and response.
In 2008, ACRIN established a cardiovascular imaging program that explores questions about the most appropriate use of CV imaging. Mitchell J. Schnall, MD, PhD is the ACRIN Network Chair and the Matthew J. Wilson Professor of Research Radiology and Professor of Radiology at the University of Pennsylvania.
As part of the NCI's restructuring of its clinical trials cooperative group program, ACRIN and the Eastern Cooperative Oncology Group (ECOG) are merging their oncology research programs and conducting research under ECOG-ACRIN Cancer Research Group.